Kevin K Ohlemiller Selected Research

Kevin K Ohlemiller Research Topics

Disease

7	Noise-Induced Hearing Loss (Acoustic Trauma) 11/2021 - 04/2007
6	Hearing Loss (Hearing Impairment) 01/2021 - 08/2014
6	Lysosomal Storage Diseases (Lysosomal Storage Disease) 05/2013 - 07/2004
3	Mucopolysaccharidosis I (Hurler Syndrome) 05/2013 - 09/2008
3	Mucopolysaccharidosis VII (Sly Syndrome) 07/2008 - 07/2002
2	Hidden Hearing Loss 11/2021 - 01/2019
2	Ototoxicity 01/2018 - 08/2014
2	Mucopolysaccharidosis III (Sanfilippo Syndrome) 05/2010 - 08/2007
2	Mucopolysaccharidoses 10/2009 - 08/2007
2	Retinal Diseases 07/2008 - 07/2004
2	Ischemia 01/2006 - 06/2002
1	Intellectual Disability (Idiocy) 01/2021
1	Thinness 11/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Sensorineural Hearing Loss 01/2018
1	Acidosis 10/2017
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 10/2017
1	Nonsyndromic Deafness 10/2017
1	Autosomal Recessive 4 Deafness 10/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2015
1	Inflammation (Inflammations) 08/2014
1	Infections 08/2014
1	Gram-Negative Bacterial Infections 08/2014
1	Deafness (Deaf Mutism) 04/2012
1	Hypertrophy 10/2009
1	Body Weight (Weight, Body) 10/2009
1	Albinism 02/2007
1	Ganglion Cysts (Ganglion) 06/2002
1	Hypoxia (Hypoxemia) 06/2002

Drug/Important Bio-Agent (IBA)

5	GlycosaminoglycansIBA 05/2013 - 07/2004
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2015
3	CalciumIBA 02/2016 - 04/2007
3	Kanamycin FDA Link 08/2014 - 06/2010
3	Iduronidase (alpha-L-Iduronidase)IBA 05/2013 - 09/2008
3	Retinaldehyde (Retinal)IBA 10/2009 - 06/2002
2	Chemokine CX3CL1IBA 01/2019 - 01/2018
2	AminoglycosidesIBA 01/2018 - 08/2014
2	alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)IBA 05/2010 - 08/2007
2	Hexosaminidases (Hexosaminidase)IBA 05/2010 - 08/2007
2	EnzymesIBA 07/2008 - 08/2007
2	GlucuronidaseIBA 07/2004 - 07/2002
1	Estrogens (Estrogen)FDA Link 11/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2021
1	Capsules (Microcapsules)IBA 11/2019
1	Pharmaceutical PreparationsIBA 11/2019
1	CX3C Chemokine Receptor 1IBA 01/2019
1	dirhodium tetraacetate (DRTA)IBA 10/2017
1	oncomodulinIBA 02/2016
1	BuffersIBA 02/2016
1	Deubiquitinating EnzymesIBA 11/2015
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 11/2015
1	Furosemide (Lasix)FDA LinkGeneric 08/2014
1	LipopolysaccharidesIBA 08/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2014
1	EndotoxinsIBA 08/2014
1	Drug CombinationsIBA 10/2013
1	Cyclophilins (Cyclophilin)IBA 04/2012
1	LigandsIBA 04/2012
1	GlucocorticoidsIBA 07/2011
1	Cholinergic Agents (Cholinergics)IBA 07/2011
1	CorticosteroneIBA 07/2011
1	Nicotine FDA Link 07/2011
1	Lysergic Acid Diethylamide (LSD)IBA 10/2009
1	MonosaccharidesIBA 10/2009
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 04/2007
1	Monophenol Monooxygenase (Tyrosinase)IBA 02/2007
1	Agouti Signaling ProteinIBA 02/2007
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2006
1	Protein Isoforms (Isoforms)IBA 01/2006
1	AcidsIBA 07/2002
1	HydrolasesIBA 07/2002
1	Oxygen (Dioxygen)IBA 06/2002

Therapy/Procedure

1	Heterologous Transplantation (Xenotransplantation) 07/2008
1	Transplantation 07/2008
1	Therapeutics 07/2004